Hongli L. Mu
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Outcomes of low-dose immune tolerance induction with single-dose rituximab in severe hemophilia A: a single-center retrospective experience.
Journal: Frontiers in immunology
Published: March 12, 2026
Treatment outcomes, safety, and characteristics of immune tolerance induction in patients with hemophilia B and inhibitors: a systematic review.
Journal: Research and practice in thrombosis and haemostasis
Published: August 12, 2025
Successful hip arthroplasty in a patient with combined deficiency of factor V and factor FVIII.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 11, 2023
A new treatment strategy for thrombotic thrombocytopenic purpura in developing countries: A single dose rituximab-contained regimen.
Journal: Thrombosis research
Published: July 20, 2022
Patients with von Willebrand disease in China: Results of an online survey.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 25, 2022
Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia.
Journal: Journal of immunology research
Published: June 14, 2020
Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune Thrombocytopenia.
Journal: BioMed research international
Published: October 23, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026